RE: Possible valuation, different scenarios26 Mar 2021 13:31
Thanks for setting this out. Discussing possible valuations is a good discipline, and a good use of a discussion board.
Margin per test and volume are - as you say - the biggest unknowns. I think the durability of demand may be a factor. I would be wary of applying multiples as you have, because they contain an implicit assumption of longevity that may not hold true. I would suggest instead taking the prospective cashflows for a foreseeable period (say 7 years) and applying a discount rate to these. This methodology can provide a better way to model the uncertainty inherent in future cashflows - for example were a superior competitor product to arrive. It's also necessary to include the impact of corporation tax; hopefully AVCT will be paying plenty of this..!
Working with your figure of £240m (10m tests x 12 months x £2)
Tax at 20% reduces this to £192m
I'll use 7 years, and a 15% discount rate (representing the annual return an investor might look for from an investment like this). Thoughts/input on these welcomed.
This gives an NPV of £799m or £3.14/share FOR THE LFT BUSINESS AS DESCRIBED IN THESE NUMBERS
If monthly volumes and margins are higher (say 15m and £3) then this changes to £1,797m or £7.08/share
Of course these numbers have to be added to whatever you think the rest of AVCT might be worth.
They do show what many of us have understood and acknowledged for some time - that some degree of expectation for LFT economics is baked into the current SP.
So, significant upside potential from where we are, although I can't get near to the £40-£50 mentioned at the end of your post on LFT alone.